- $13.75m
- $40.37m
- $2.91m
Brief: Osr Holdings Inc - In Preliminary Discussions For Acquisition Of 16% Controlling Stake In Sillajen - SEC Filing
Brief: Osr Holdings Inc - Vaximm AG Enters Binding Term Sheet With Bcm Europe AG - SEC Filing
Brief: Vaximm, An Osr Company, Receives Binding Term Sheet From Bcm Europe For Global Exclusive License Of Vxm01 With $30M Upfront And Up To $815M In Milestones
Brief: OSR Holdings Says Woori IO Shareholders Approve Share Exchange To Become Unit Of Co
Brief: OSR Holdings Says Vaximm AG Shortens Exclusivity Period With BCM Europe To Three Months
Brief: OSR Holdings Signs Definitive Agreement To Acquire Woori IO
Brief: OSR Holdings Says Chardan Files Action Against OSR Holdings & Kuk Hyoun Hwang In New York
Brief: OSR Holdings Provides Transparency Update On Equity Financing Instruments
Brief: OSR Holdings Announces Strategic Roadmap For Tokenization Under Reg D Framework
Brief: OSR Holdings Entered Common Stock Purchase Agreement With White Lion GBM Innovation Fund
Brief: Vaximm AG Reports Phase 2A Results For VXM01 And Avelumab Combo In Glioblastoma
Brief: OSR Holdings Appoints Dr. Constance Höfer as Chief Scientific Officer
Brief: Bellevue Life Sciences Acquisition Says Received Notice From Nasdaq Notifying Co No Longer Meets Minimum 300 Public Holders Requirement On Feb 15
Brief: Osr Holdings Enters Into Business Combination Agreement With Bellevue Life Sciences Acquisition
Brief: Bellevue Life Sciences Acquisition Corp. And Osr Holdings Sign An Exclusive Letter Of Intent For A Business Combination